Sun Pharmaceutical Industries has entered into agreements to acquire minority stake in the following entities which are non-material investments by the Company in the allied areas.
1. Agreement to acquire equity shares (up to 26.09%) of Agatsa Software, which is is an early-stage digital diagnostic devices company.
2. Agreement to acquire equity shares (27.39%) of Remidio Innovative Solutions, which provides innovative products enabling early detection of eye diseases.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
